key: cord-0935505-ii6g1x2i
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: COVID‐19 vaccination and lichen palnus
date: 2021-11-03
journal: Oral Dis
DOI: 10.1111/odi.14050
sha: 198ff4e07bcc0abac9335c12241e37c7c8a6f5e4
doc_id: 935505
cord_uid: ii6g1x2i

nan

vaccination, it might be possible. An important possible pathogenesis of vaccine-induced lichen planus is autoimmune development triggered by epitope. A good example of the epitope of vaccine that can trigger autoimmune is epitope S (Limas & Limas, 2002) . In case that it is an abnormal immunity process or autoimmunity, an abnormal antibody specific to the vaccine epitope should be detectable (Calista & Morri, 2004) . However, in the report by Troeltzsch et al. (2021) , there is no data on complete work-up for autoimmunity and antibody profile.

Another possible underlying mechanism is vaccine-associated hyperviscosity. After COVID-19 vaccination, hyperviscosity might occur (Joob & Wiwanitkit, 2021) . The mechanism of vaccine induces hyperviscosity is due to an antibody surge after vaccine administration, which results in a rapid increase of plasma concentration (Joob & Wiwanitkit, 2021) . This pathological process is confirmed as a possible pathomechanism of some COVID-19 vaccine-related adverse effects, such as zoster-like dermatological lesions (Mungmunpuntipantip & Wiwanitkit, 2021) . In the case of the hyperviscosity problem, lichen planus is a rare but possible clinical presentation (Xiao, 1990; Xu, 1991) . Xiao investigated primary contributing factors in hemorheology of oral lichen planus and identified high blood viscosity as an important factor (Xiao, 1990 ). Xu (1991) found that high blood viscosity results in the disturbance of microcirculation and further induced inflammation process underlying lichen planus formation. A good example is the occurrence of lichen planus in polycythemia disorder, which also has a hyperviscosity problem. Therefore, if hyperviscosity occurs after COVID-19 vaccination, it might induce the formation of lichen planus (Oueslati et al., 2020) . Again, no laboratory data are available in the report by Troeltzsch et al. (2021) ; hence, it is difficult to confirm that lichen planus in the case presented by Troeltzsch et al. should be due to which pathogenesis. 

Oral lichen planus following the administration of vector based COVID-19 vaccine (Ad26.COV2.S). Oral Diseases

Primary investigation of multiple factors in hemorrheology of oral lichen planus

A study on the microcirculation and hemorheology of oral lichen planus